Advertisement
IART vs UTMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IART is a Hold and UTMD is a StrongBuy.
IART in upward trend: price rose above 50-day moving average on November 10, 2026
IART moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IART's RSI Oscillator exited the oversold zone, 23 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on IART as a result. In 59 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for IART just turned positive on October 29, 2026. Looking at past instances where IART's MACD turned positive, the stock continued to rise in 25 of 43 cases over the following month. The odds of a continued upward trend are 58%.
Following a +8.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IART advanced for three days, in 182 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 56 cases where IART's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IART declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
IART broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IART entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.000) is normal, around the industry mean (4.142). IART has a moderately low P/E Ratio (-149.111) as compared to the industry average of (3.291). Projected Growth (PEG Ratio) (0.669) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.751) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. IART’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IART’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
UTMD in upward trend: price may jump up because it broke its lower Bollinger Band on October 27, 2026
UTMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 39 cases where UTMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UTMD's RSI Indicator exited the oversold zone, 11 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 44%.
The Moving Average Convergence Divergence (MACD) for UTMD just turned positive on November 09, 2026. Looking at past instances where UTMD's MACD turned positive, the stock continued to rise in 33 of 51 cases over the following month. The odds of a continued upward trend are 65%.
UTMD moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTMD advanced for three days, in 137 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UTMD as a result. In 62 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The 10-day moving average for UTMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. UTMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.879) is normal, around the industry mean (4.964). P/E Ratio (22.021) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (5.980) is also within normal values, averaging (4.143). Dividend Yield (0.017) settles around the average of (0.005) among similar stocks. P/S Ratio (6.549) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IART | UTMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 31 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 82 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 91 | 75 | |
PRICE GROWTH RATING 1..100 | 54 | 47 | |
P/E GROWTH RATING 1..100 | 15 | 13 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IART's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for UTMD (82). This means that IART’s stock grew significantly faster than UTMD’s over the last 12 months.
IART's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as UTMD (100). This means that IART’s stock grew similarly to UTMD’s over the last 12 months.
UTMD's SMR Rating (75) in the Medical Specialties industry is in the same range as IART (91). This means that UTMD’s stock grew similarly to IART’s over the last 12 months.
UTMD's Price Growth Rating (47) in the Medical Specialties industry is in the same range as IART (54). This means that UTMD’s stock grew similarly to IART’s over the last 12 months.
UTMD's P/E Growth Rating (13) in the Medical Specialties industry is in the same range as IART (15). This means that UTMD’s stock grew similarly to IART’s over the last 12 months.
| IART | UTMD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | 2 days ago 44% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 62% | 2 days ago 61% |
| MACD ODDS (%) | 2 days ago 58% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 46% |
| Advances ODDS (%) | 2 days ago 62% | 3 days ago 56% |
| Declines ODDS (%) | 6 days ago 78% | 14 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 73% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 73% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IART’s FA Score shows that 2 FA rating(s) are green while UTMD’s FA Score has 1 green FA rating(s).
- IART’s FA Score: 2 green, 3 red.
- UTMD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IART’s TA Score shows that 5 TA indicator(s) are bullish while UTMD’s TA Score has 5 bullish TA indicator(s).
- IART’s TA Score: 5 bullish, 4 bearish.
- UTMD’s TA Score: 5 bullish, 4 bearish.
Price Growth
IART (@Medical/Nursing Services) experienced а +6.60% price change this week, while UTMD (@Pharmaceuticals: Other) price change was +4.06% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
Reported Earning Dates
IART is expected to report earnings on Mar 03, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+1.96% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
IART and
Correlation & Price change
A.I.dvisor indicates that over the last year, IART has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then RVTY could also see price increases.
| Ticker / NAME | Correlation To IART | 1D Price Change % | ||
|---|---|---|---|---|
| IART | 100% | +1.11% | ||
| RVTY - IART | 49% Loosely correlated | -1.01% | ||
| CNMD - IART | 48% Loosely correlated | -1.41% | ||
| MTD - IART | 44% Loosely correlated | -0.62% | ||
| A - IART | 43% Loosely correlated | -1.27% | ||
| AZTA - IART | 43% Loosely correlated | -1.15% | ||
More | ||||
UTMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.
| Ticker / NAME | Correlation To UTMD | 1D Price Change % | ||
|---|---|---|---|---|
| UTMD | 100% | -0.01% | ||
| CERS - UTMD | 50% Loosely correlated | -5.80% | ||
| TMCI - UTMD | 47% Loosely correlated | +2.09% | ||
| INMD - UTMD | 47% Loosely correlated | -1.81% | ||
| ITGR - UTMD | 44% Loosely correlated | +0.05% | ||
| IART - UTMD | 43% Loosely correlated | +1.11% | ||
More | ||||